Related Experiment Video
Updated: Apr 29, 2026

07:56
Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development
Published on: January 26, 2018
20.0K
[Modulation of myometrium mitochondrial membrane potential by calmodulin antagonists]
Ukrainian Biochemical Journal
|May 20, 2014
Summary
Calmodulin antagonists affect mitochondrial membrane potential in rat myometrium cells. Specific antagonists like calmidazolium and trifluoperazine were shown to alter mitochondrial polarization using fluorescent probes.
Area of Science:
- Cell Biology
- Biochemistry
- Pharmacology
Background:
- Mitochondrial membrane potential is crucial for cellular energy production and function.
- Calmodulin antagonists are known to affect various cellular processes, but their impact on mitochondrial function requires further elucidation.
Purpose of the Study:
- To investigate the influence of calmodulin antagonists on mitochondrial membrane potential in rat myometrium cells.
- To determine the dose-dependent effects of specific calmodulin antagonists on mitochondrial polarization.
Main Methods:
- Flow cytometry and confocal microscopy were employed to assess mitochondrial membrane potential.
- Potential-sensitive fluorescent probes, tetramethylrhodamine methyl ester (TMRM) and MitoTracker Green (MTG), were utilized.
Main Results:
- Calmidazolium (1-10 µM) gradually reduced mitochondrial membrane potential.
- Trifluoperazine exhibited differential effects: 10 µM increased polarization, while 100 µM caused significant depolarization.
- Calmodulin antagonists led to a decrease in TMRM fluorescence, indicating modulation of mitochondrial membrane potential.
Conclusions:
- Calmodulin antagonists modulate the mitochondrial membrane potential in myometrium cells.
- The findings highlight a novel mechanism by which calmodulin antagonists can impact cellular bioenergetics.
Related Concept Videos
Calmodulin-dependent Signaling
5.0K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.0K
Smooth Muscle Contraction
8.6K
Smooth muscle contraction is a complex process vital for various bodily functions, from maintaining blood vessel tension to facilitating the movement of food through the digestive tract. Unlike striated muscles, smooth muscle contraction begins more slowly and lasts longer.
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
8.6K
Antihypertensive Drugs: Action of Calcium Channel Blockers
2.4K
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
2.4K
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
3.6K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
3.6K

